FDA Grants Approval to Therapy for Advanced, Refractory Melanoma

The FDA has approved a new therapy for treating advanced melanoma that is resistant to a widely-used class of immunotherapy drugs. This approval expands treatment options for patients with this challenging form of skin cancer.